Midgard Science

Labs / CDMO: development & manufacturing

Amyl Tx

Liège, Belgium · amyltx.com

Amyl Therapeutics is a preclinical-stage biotechnology company in Liège, Belgium. It develops Pan-Amyloid Immunotherapy for amyloid-mediated neurodegenerative diseases such as Alzheimer’s and Parkinson’s, and for systemic amyloidosis.

They take quote requests by email.

What they offer

  • Pan-Amyloid Immunotherapy development

    Develops therapeutic candidates designed to selectively target a common structural conformation shared across amyloid aggregates.

  • Amyloid aggregate clearance

    Works on clearing toxic amyloid aggregates in later stages of disease.

  • Amyloid formation inhibition

    Designs candidates to inhibit the formation of amyloid aggregates in earlier disease stages.

  • Neurodegenerative disease therapeutic research

    Advances a universal approach aimed at treating amyloid-mediated neurodegenerative diseases.

What they work on

Modalities
Antibody
Therapeutic areas
neurodegenerative diseases, Alzheimer’s disease, Parkinson’s disease, systemic amyloidosis, amyloid-mediated diseases
Sites
Liège, Belgium
Founded
2020

Similar labs. 3C Therapeutics, Adragos Pharma, AGC Biologics, Alphalyse

Found in a contract services directory. Listing built from amyltx.com. Work here? Claim this listing.

Amyl Tx · Midgard Science